(888) 552-6760 SCHEDULE AN APPOINTMENT

Alexandra Wong,

Medical Oncologist and Hematologist

Biography photo
Location
West Covina
1250 South Sunset Avenue, Suite 303
West Covina, CA 91790
Education
Medical school:
Degrees
  • 2018, Doctor of Medicine, New York Medical College, Valhalla, New York
Fellowship
  • 2024, Fellowship and Co-Chief Fellow, Hematology/Oncology, USC/Los Angeles General Medical Center, Los Angeles, California
Residency
  • 2021, Residency, Internal Medicine, USC/Los Angeles General Medical Center, Los Angeles, California
Professional Experience
  • 2024-present, Assistant Clinical Professor, Department of Medical Oncology & Therapeutics Research, City of Hope, West Covina, California
Academic Appointments
  • Assistant Clinical Professor, Department of Medical Oncology & Therapeutics Research
About Me

Alexandra Wong, M.D., an assistant professor in the Department of Medical Oncology & Therapeutics Research at City of Hope® West Covina, is a physician-scholar focused on developing groundbreaking new therapies in the field of hematology-oncology. As a clinical provider, she recognizes the importance of creating individualized treatment plans for each patient, many of which incorporate leading-edge treatment options.

After earning her medical degree at New York Medical College in Valhalla, New York, Dr. Wong completed a residency and fellowship in hematology-oncology at USC/Los Angeles General Medical Center, where she also served as co-chief fellow. Board certified in internal medicine, she is a member of the American Society of Hematology and American Society of Clinical Oncology. 

Dr. Wong particularly enjoys the continuity of care that hematologist-oncologists have with their patients and is dedicated to supporting patients throughout their cancer journey.

Patient ratings
Star ratings and comments are only available for medical, radiation and gynecologic oncologists. Gynecologic surgical offerings are not included at this time due to a different survey tool required to evaluate these services. CTCA uses a validated Press Ganey® survey, which captures patient experience feedback for the primary oncology services of chemotherapy and radiation therapy at our comprehensive care and research centers. Following industry best practice, star ratings and comments are only published for physicians with a minimum of 30 completed patient surveys.